Below you will find an overview of the funding obtained throughout the SafeBoosC project. The funding is listed in chronologically order.

2012, January: The SafeBoosC-II trial was supported with a grant of 11.1 mio dkk from The Danish Council for Strategic Research. 750,000 DKK was intended to support the development of a new cerebral oximeter (OxyPrem) at the Biomedical Optics Research Laboratory at the Division of Neonatology at the University Hospital Zurich, Switzerland

2018, April: the SafeBoosC-III trial was supported with a grant of 2.7 mio dkk from The Elsass Foundation.

2018 – 2021: For the SafeBoosC-III trial, the central trial unit in Copenhagen did not receive any funding to cover local expenses in participating centres. Thus, centres wanting to participate had to find a way to cover such expenses themselves. 

A list of local funders across the participating centres can be found here.

The list will be updated on a continuous basis as all information is gathered from the local principal investigators. 

2019, October: The SafeBoosC-III trial was supported with a grant of 1.0 mio dkk from Svend Andersen Foundation.

2019, November: The SafeBoosC-III trial was supported with a grant of 1.0 mio dkk from Aage and Johanne Louis-Hansen Foundation. 

2020, December: The SafeBoosC-III trial was supported with a grant of 600,000 DKK from The Elsass Foundation

For a more detailed description of the funding process, click here.